Inventiva S.A. American Depository Shares(IVA)

Stock quote, options chain, IV rank, technicals, AI analysis, and institutional ownership.

Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.

IVA $3.38 —
Snapshot
$3.38
52-Week Range
$3.10 – $7.98
YTD
-28.91%
IV Rank (30D)
100
Straddle Price
$5.03
P/C Vol Ratio
7.33
Market Cap
$0.8B
Fair Value
MODEL: SHORT

A blended fair-value estimate combining up to six valuation methods. Each method is weighted by how well it fits the company — DCF down-weights for unprofitable names; DDM only fires for steady dividend payers; comparables down-weight when peer multiples disagree.

  • DCF (quality-aware) — projects free cash flow with a horizon that scales to business quality. True compounders (quality 6/6) get 10 years explicit + 10 years fade before terminal; cyclical/struggling names (quality 0-1) get a 5-year terminal cliff. Quality is scored from ROE, gross margin, growth, FCF margin, debt load, and FCF consistency — the same factors that drive market premium for compounders.
  • Market-Implied Growth (in Model Inputs) — reverse-DCF that answers "what growth rate is the market pricing in?". Lets you sanity-check the deviation: if implied growth is plausible for the business, the model's bearish flag may be wrong; if implausible, the market may be over-extrapolating.
  • DDM (Gordon Growth Dividend Model) — values the stream of future dividends. Only used when trailing yield ≥ 2% and dividend payments are stable — below that the dividend is a token payout and Gordon (which values only the dividend stream) systematically underprices growth names, so those route to DCF + comparables + market anchor instead.
  • P/E, EV/EBITDA, P/B, P/S — applies the peer-group median multiple to this company's per-share metric. Peers come from the same set as the "Related symbols" card. Earnings/sales metrics are forward-tilted by the company's recent revenue growth (capped at 25%) so they're comparable to peers' growth-embedded multiples — mimics how analysts use NTM rather than TTM. Per-multiple weights are biased by company quality (e.g. P/B down-weighted for asset-light tech).
  • Market Anchor (SMA50) — the 50-day moving average, weighted by recent trading-range stability (tighter Bollinger bands → higher weight). Captures information fundamentals miss (forward consensus, sentiment, supply/demand) — but only when recent trading is steady enough that the market has converged on a view. During wild breakouts or breakdowns the anchor's weight collapses.
  • Options Expected (B-L 30d) — the risk-neutral expected stock price at 30-day options expiration, derived from the full implied-volatility surface via Breeden-Litzenberger (second derivative of call price wrt strike → implied PDF, then E[S_T]). Forward-looking, captures all options-implied information (smile, skew, term structure) in one number. Weighted by chain liquidity. SP500-only at present (pre-computed daily). Backtest evidence: adds modest alpha across most bucket × holding combos.
  • Blended value — weighted average. Confidence reflects how many methods fired and how tight peer dispersion is.
  • Deviation pill — green when blended FV ≥ 10% above current price (undervalued); red when ≥ 10% below; grey otherwise.
10-yr Treasury (rf)4.96%
Beta vs SPY0.93
Cost of Equity (CAPM)9.62% (VRP-adj)
WACC9.65%
Volatility Risk Premium+315.5pp (IV − HV30)
Effective Tax Rate21.0%
Rev. Growth (YoY, DCF input)+3.0%
DCF Horizon5 years explicit + fade
Forward Tilt (NTM/TTM)×1.03 (applied to P/E, EV/EBITDA, P/S)
Quality Score0/6 — cyclical/struggling (5y DCF)
SMA 50$4.44 (Market Anchor value)
SMA 20 / Bollinger Mid$4.19
Bollinger Width / SMA201205.0% (drives anchor stability)
Net Debt$0.0B
Peers used for multiples: ABEO, ACHV, CLDX, DCTH, MIST, PAGP, PHAT, VRDN
Model Conviction
27%
20-Day Fair Value
≈ by Oct 26, 2026
$3.57
α +4.2% rank 82%
40-Day Fair Value
≈ by Nov 24, 2026
$3.51
α +2.4% rank 82%
60-Day Fair Value
≈ by Dec 23, 2026
$3.32
α -3.0% rank 82%
MethodImplied PriceWeightDetail
DCF n/a 0%
DDM (Gordon) n/a 0%
Peer P/E n/a 0%
Peer EV/EBITDA n/a 0%
Peer P/B n/a 0% median 3.4× · 5 peers
Peer P/S n/a 0% median 12.4× · 7 peers
Market Anchor (SMA50) $4.44 100% stability 72% (BB-width)
Options Expected (B-L 30d) n/a 0%
As of 2026-09-25 · updated
Info
Exchange
XNAS
Market Cap
$0.8B

Inventiva SA is a France-based clinical-stage biopharmaceutical company focused on the development of oral small-molecule therapies for the treatment of MASH. The wholly-owned research and development facility and a team with expertise and experience in the development of compounds that target nuclear receptors, transcription factors and epigenetic modulation. Leveraging the expertise, the company is also advancing lanifibranor for the treatment of MASH and has a pipeline of earlier-stage therapeutic programs in oncology. It operates in the segment of Service delivery and clinical stage resear…

Summary
—
composite
—
No summary data available for this symbol yet.

Each spoke is this symbol's rank within its sector (0–100; the dotted ring marks the sector median at 50). Higher is more constructive for a long. One spoke — News sentiment — is an absolute reading, not a sector rank. Grayed spokes have no data. A fuller shape is a summary, not a recommendation.

Chart
Seasonality
MonthAvg ReturnYears of Data
Jan +8.85% 6
Feb +1.81% 6
Mar -5.57% 6
Apr -10.46% 6
May +4.53% 6
Jun -12.74% 6
Jul -2.58% 6
Aug -4.33% 6
Sep -2.20% 6
Oct +10.55% 5
Nov -1.78% 5
Dec -0.89% 5
Technical Indicators

Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.

Trend Indicators
  • SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
  • EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
  • MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
  • ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
  • +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
Momentum Oscillators
  • RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
  • Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
  • Williams %R — inverted scale: <−80 oversold, >−20 overbought.

Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.

Volume & Volatility
  • Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
  • OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
  • Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
  • ATR / True Range — average daily $ move; sizing and stop-loss reference.
  • HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.

Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →

Trend Indicators

SMA 20: $4.12
SMA 50: $4.42
SMA 200: $5.05
Current: $3.38
EMA 12: $3.74
EMA 26: $4.06
MACD: -0.3193 | Signal: -0.0879
BEARISH
ADX (14): 31.76
TREND
+DI: 9.32
−DI: 32.50

Momentum Oscillators

RSI (14): 24.93
OVERSOLD
Stoch %K: 9.33
Stoch %D: 7.69
Williams %R: -83.77

Volume & Volatility

BB Upper: $5.18
BB Lower: $3.05
NEUTRAL
OBV: 6,339,885
Vol SMA 20: 1,608,542
Vol ROC: 44.17%
ATR: $0.25
True Range: $0.27
HV 20: 45.1%
HV 30: 43.7%
HV 60: 57.0%

Data Summary

Data Points: 500
Last Updated:
Date Range: 2024-09-25T00:00:00 – 2026-09-24T00:00:00
AI Analysis

LLM Stock Analysis Report

Executive Summary

Overall Assessment: NEUTRAL (Confidence Level: 6/10)

Key Drivers and Primary Risks:

  • Recent positive news headlines related to financing and debt repayment may have contributed to the stock's recent price move.
  • High volatility, as indicated by beta and historical volatility metrics, suggests that the stock is more prone to large price movements.

2-3 Sentence Investment Thesis: IVA's recent price action appears to be driven by a combination of positive news sentiment and technical momentum signals. However, high volatility and a relatively high IV rank suggest that the stock may be due for a potential pullback or mean reversion. Further analysis is needed to determine the likelihood of continued upward movement.

Recent News Sentiment Impact: The recent news headlines appear to have had a positive impact on the stock's price, with sentiment trending positively across the last 5 articles. This suggests that the market is responding favorably to Inventiva's financing and debt repayment efforts.

Technical Analysis

Trend Direction:

  • Short-term (1-4 weeks): Bullish
  • Medium-term (1-3 months): Neutral
  • Long-term (3-12 months): Bearish

Support/Resistance Levels: The stock is trading above its short-term moving averages, with resistance at $4.89 and support at $4.56.

Momentum Signals:

  • RSI: 54.55 (neutral)
  • MACD signal line crossovers are bullish.
  • Bollinger Bands signal is neutral.

Volume Analysis: Volume has been trending upward over the past few days, suggesting institutional buying interest.

News & Sentiment Analysis

Recent Headlines Summary: The last 5 news articles have been primarily positive in nature, with headlines related to financing and debt repayment efforts.

Sentiment Assessment: Overall sentiment is positive, with a majority of articles having a positive tone.

Catalyst Identification: Upcoming earnings release may provide further direction for the stock's price action.

Market Narrative: The market appears to be responding favorably to Inventiva's recent news headlines, which has contributed to the stock's upward momentum.

Risk & Volatility Assessment

Beta Interpretation: Beta is high at 1.34, indicating that the stock moves more than the broader market.

Volatility Regime: Current volatility levels are relatively high compared to historical averages.

Options Market Signals: IV rank is low, suggesting that options market pricing is relatively low. Put/call ratio is bearish, indicating that traders are betting on a potential pullback.

Downside Protection: Support levels are present at $4.56, which could provide some downside protection in the event of a pullback.

Market Context & Positioning

Sector Performance: Inventiva's sector (healthcare) has been performing relatively well recently, with some stocks experiencing significant price moves.

Institutional Activity: Institutional buying interest is evident based on volume trends and put/call ratios.

Correlation Analysis: The stock is highly correlated to the broader market, as indicated by a high beta value.

Relative Valuation: The stock appears to be trading within a relatively tight range, with some resistance present at $4.89.

Key Levels & Action Items

Critical Price Levels:

  • Support at $4.56
  • Resistance at $4.89

Breakout/Breakdown Levels:

  • Breakout above $4.89 could lead to further upward momentum.
  • Breakdown below $4.56 could indicate a potential pullback.

Time-Sensitive Catalysts: Upcoming earnings release may provide further direction for the stock's price action.

Risk Management: Stop-loss levels should be set around $4.50, with position sizing considerations based on risk tolerance and volatility expectations.

Generated
Options Activity
IV Rank (30D)
100
IV Rank (7D)
100
Avg IV
477.9%
Straddle (30D)
$5.03
Straddle (7D)
$5.03
P/C Volume
7.33
Spread Scanner GPU

Each spread is ranked by a composite score built in three stages. Full documentation →

Stage 1 — Base Score (GPU scanner)

score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.

Stage 2 — Skew Adjustment (±25% cap)

RR and BF (30-delta) from the persisted per-symbol skew snapshot — wing strikes picked by real greeks.delta, not a moneyness proxy. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.

Stage 3 — Technical Overlay (±50% cap, 5 groups)
Group 1 · Directional Bias (±0.25)
  • RSI <40 bullish / >60 bearish
  • MACD crossover + histogram trend
  • Price vs SMA 50 & SMA 200
Group 2 · Momentum (±0.10)
  • Stochastic %K <20 / >80
  • Williams %R <−80 / >−20
Group 3 · Volatility (up to −0.25 / +0.15)
  • Blended ATR + straddle expected-move penalty
  • Bollinger Band signal (+ counter-trend penalty)
  • BB width — vol contraction boost for ICs
Group 4 · IV Regime (±0.15)
  • IV rank ≥ 75 → strong boost for credit spreads
  • IV rank < 25 → penalty (selling cheap vol)
Group 5 · Liquidity (penalty up to −0.10)
  • Min open interest across all legs
  • OI < 100 → −0.10 · OI < 500 → −0.05

score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →

Enter a ticker to scan for optimal spread opportunities.

Evaluates all bull put, bear call, iron condor, and calendar spread combinations using GPU-accelerated analysis.

Skew (Wing IV − ATM IV)
DTE:
Wing Δ:
Metric:
Wing vs ATM
IV(put wing) − IV(ATM), in vol points

How much the OTM put trades above (or below) the at-the-money strike. Measures the height of the put-side tail relative to ATM — i.e. how expensive crash insurance is on this name.

  • Positive (typical) — wing IV > ATM IV. Standard equity put skew: portfolios bid up crash protection, so OTM puts trade richer than ATM.
  • Near zero or negative (unusual) — wing IV ≤ ATM IV. Flat or inverted put side. Common when there's no fear demand, in tightly mean-reverting names, or right after an earnings catalyst clears.
  • Percentile vs own 3-yr history: high = wings rich (good time to sell wing premium); low = wings cheap (good time to buy protection).
  • Not directional — high or low wings don't predict up or down moves. It's a price tag on tail insurance, not a forecast.
Risk Reversal
IV(call wing) − IV(put wing), equal delta on each side

Which side of the smile is the market paying up for? Measures the tilt of the surface — call skew vs put skew at matched deltas.

  • Negative (typical) — puts richer than calls. Standard equity behavior: hedging demand makes puts carry a premium. Most large-caps sit in the −1 to −5 vol-point range.
  • Strongly negative (< −5 pts) — heavy downside hedging, elevated fear, or an upcoming catalyst (earnings, FDA, macro event). Worth flagging.
  • Positive — calls richer than puts. Unusual for equities; signals bullish momentum, short-squeeze positioning, or takeover/M&A speculation.
  • Near zero — symmetric surface. Market sees roughly equal up/down risk. Rare for large-caps; more common in commodities and FX.
Reading them together

Wing-vs-ATM tells you how expensive the tails are. Risk Reversal tells you which side is favored. Combined:

  • High wing percentile + deeply negative RR → strong put bid; stress or major event priced in. Owning protection costs a premium; selling put premium is dangerous.
  • Low wing percentile + near-zero RR → complacency; insurance cheap and balanced. Good environment to add cheap downside hedges.
  • Positive RR + elevated wings → call-side fear-of-missing-out; common in squeeze setups. Upside calls expensive, downside puts not bid.
14 DTE / 10d —
— pts EXTREME
ATM — / Wing —
30 DTE / 10d —
— pts EXTREME
ATM — / Wing —

Percentile is the rank of today's reading within ~3 years of this symbol's own history. High percentile = wings are rich relative to history; not a directional signal. Skew is read off the chain in real time, not from CBOE SKEW.

Volatility Surface

Enter a ticker to render the implied volatility surface.

Volatility Smile

Enter a ticker to render the implied volatility smile.

IV Rank (7 DTE)
IV Rank (30 DTE)
Straddle Price (30 DTE)
Beta Analysis
Beta (1Y vs SPY)
1.33
Correlation (SPY)
22.8%
R²
0.05
Ann. Volatility
75.9%
SPY Volatility
13.0%

High volatility - stock moves more than market

Beta & Alpha Over Time
Institutional Ownership (13F)
Latest filings — 2026-06-30

Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.

  • Shares — long equity positions in this name, aggregated across share classes.
  • Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
  • % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
  • Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.

Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.

88 filers85,297,360 shares$322.20M value
# Filer Shares Value % of Total % of Float Period
1 Caligan Partners LP 8,163,191 $30.86M 9.58% — 2026-06-30
2 Samsara BioCapital, LLC 6,314,805 $23.87M 7.41% — 2026-06-30
3 Paradigm Biocapital Advisors LP 4,000,000 $15.12M 4.69% — 2026-06-30
4 Andera Partners 3,633,181 $13.73M 4.26% — 2026-06-30
5 ADAR1 Capital Management, LLC 3,606,656 $13.63M 4.23% — 2026-06-30
6 MILLENNIUM MANAGEMENT LLC Custodian 3,512,174 $13.28M 4.12% — 2026-06-30
7 SymBiosis Capital Partners, LLC 2,354,000 $13.06M 4.05% — 2026-03-31
8 Nantahala Capital Management, LLC 2,686,393 $10.15M 3.15% — 2026-06-30
9 Trails Edge Capital Partners, LP 2,657,997 $10.05M 3.12% — 2026-06-30
10 FRANKLIN RESOURCES INC Custodian 2,642,611 $9.99M 3.10% — 2026-06-30
11 Squadron Capital Management LLC 2,435,000 $9.20M 2.86% — 2026-06-30
12 Woodline Partners LP 2,323,149 $8.78M 2.73% — 2026-06-30
13 Aberdeen Group plc 2,307,773 $8.72M 2.71% — 2026-06-30
14 UBS Group AG Custodian 2,305,192 $8.71M 2.70% — 2026-06-30
15 BOOTHBAY FUND MANAGEMENT, LLC 2,003,782 $7.57M 2.35% — 2026-06-30
16 Patient Square Capital LP 1,967,171 $7.44M 2.31% — 2026-06-30
17 NEXTBio Capital Management LP 1,787,984 $6.76M 2.10% — 2026-06-30
18 CITADEL ADVISORS LLC Custodian 1,784,566 $6.75M 2.09% — 2026-06-30
19 Point72 Asset Management, L.P. 1,683,012 $6.36M 1.97% — 2026-06-30
20 Integral Health Asset Management, LLC 1,520,000 $5.75M 1.78% — 2026-06-30
21 Yu Fan 1,500,000 $5.67M 1.76% — 2026-06-30
22 NEA Management Company, LLC 1,462,586 $5.53M 1.72% — 2026-06-30
23 STEMPOINT CAPITAL LP 1,426,320 $5.39M 1.67% — 2026-06-30
24 Propel Bio Management, LLC 1,281,212 $4.84M 1.50% — 2026-06-30
25 KINGDON CAPITAL MANAGEMENT, L.L.C. 1,270,000 $4.80M 1.49% — 2026-06-30
# Filer Notional Value % of Total Period
# Filer Notional Value % of Total Period
Insider Activity
Latest: 2010-10-13
Form 4 filings — insider beneficial-ownership changes by officers, directors, and 10%+ holders. Filed within 2 business days of transaction.
Filed Reporter Role Action Shares Avg Price Net $ Link
2010-10-13 JOSEPH C VISCONTI CEO, President, Chairman Sell (S) +24,000 $0.14 $3.4K EDGAR
2010-07-12 JOSEPH C VISCONTI CEO, President, Chairman Sell (S) +24,000 $0.14 $3.4K EDGAR
2008-12-10 JOSEPH C VISCONTI President & CEO Buy (P) +45,500 $0.15 $6.7K EDGAR
2008-11-14 JOSEPH C VISCONTI President & CEO Buy (P) +67,100 $0.18 $12.1K EDGAR
2008-09-16 JOSEPH C VISCONTI President & CEO Buy (P) +19,300 $0.25 $4.8K EDGAR
2007-11-28 JOSEPH C VISCONTI President and CEO Buy (P) +16,800 $0.58 $9.7K EDGAR
2007-08-29 JOSEPH C VISCONTI President and CEO Buy (P) +500 $1.00 $500 EDGAR
2007-08-20 JOSEPH C VISCONTI President and CEO Buy (P) +4,500 $1.95 $8.8K EDGAR
2007-08-13 JOSEPH C VISCONTI President and CEO Buy (P) +236,507 $3.50 $827.8K EDGAR
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (described in filing footnote — typically 401(k), trust, inheritance) · W = will/inheritance. Only P / S codes carry directional signal.
ETF Holders
# ETF Provider Weight $ Exposure ETF AUM As Of
Fundamentals

Quarterly filings sourced from SEC 10-Q / 10-K reports. TTM tiles aggregate the most recent four quarters; bars show the last ~12 quarters oldest → newest.

Metrics
  • Revenue — top-line sales. Look for consistent YoY growth; seasonal businesses need same-quarter comparisons (Q4 '24 vs Q4 '23).
  • Net Income — bottom-line profit after all expenses. Can be volatile from one-time items; red bars = net loss.
  • Diluted EPS — net income per share assuming options/converts are exercised. Direct input to the P/E ratio.
  • Operating Cash Flow — cash generated from core operations, before capex and financing. Harder to manipulate than net income; growing OCF is a quality signal.
How to read the bars
  • Sequential growth — quarter-over-quarter trend. Accelerating bars are a momentum signal.
  • YoY growth — compare to the same quarter a year earlier to remove seasonality.
  • Quality — OCF should roughly track Net Income over time. Large divergence (net income ≫ OCF) flags accruals risk.
  • Margins — scan the bar ratios: Net Income / Revenue tells you margin trend without needing a separate chart.

TTM (trailing-twelve-month) smooths seasonality and is used for the P/E calculation. Filings appear 30–90 days after the period closes.